Slots: Each institution is allowed a maximum of one nomination per grant cycle to one of the Pathway Program Award types: Initiator or Accelerator. Institutions may not submit nominations in multiple award types in a single grant cycle.
Deadlines
Internal Deadline: Friday, June 9, 2023, 5pm PT
LOI: N/A
External Deadline: August 1, 2023, 2pm PT (5pm ET)
Award Information
Award Type: Grant
Anticipated Award Amount: $325,000/year
Who May Serve as Applicant: Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
Candidates will be identified through institutional nominations. Applications will be accepted from only individuals with the appropriate institutional support; any applications received without the appropriate institutional nomination will be administratively disapproved. Applicants must hold independent faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K or R awards, including an initial NIH R01) but must not have applied for, or received, an NIH R01 renewal or a second R01 award. Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree. Candidate’s appointment at the Sponsoring Institution must be full-time. Rare exceptions to full-time positions may be granted on a case-by-case basis and must be pre-approved by Pathway administration staff prior to application submission. Applications are open to individuals with current research positions at university-affiliated institutions or other non-profit research institutions within the United States and U.S. possessions. Individuals must have permission to work within the U.S., either as U.S. citizens or permanent residents, or with appropriate work visas/permits. Institutional confirmation of permission to work within the U.S. will be required at the time of application submission. One person must be specified as the PI; co-PIs are not permitted.
Accelerator applicants must agree to devote at least 75% of total time and effort towards research during the period of Association funding with a commitment of 25-50% effort towards the Accelerator Award if funded. In other words, 75% of the PI’s time overall must be dedicated to research. This percentage includes time dedicated to the Association-funded grant in addition to grants supported by other funding agencies. Applicants are required to provide an Institutional Nomination Letter from the appropriate institutional representative responsible for the final approval of the nomination submission (Chair of Nominating Committee, Dean of Research, Division Head, etc.), co-signed by the applicant’s Division or Department Head, delineating the institution’s nomination and commitment to the applicant. In addition, applicants must provide a completed Nomination Form, signed by the appropriate institutional representatives, acknowledging the nomination and endorsing the grant application (see Sponsoring Institution Stipulations below). Nomination materials must be submitted through the Association’s online Grant Management Site at the time of application. The Association will not accept such materials separately after the application deadline. Applications submitted without the appropriate nomination forms are considered incomplete and will be administratively disapproved.
Link to Award: https://professional.diabetes.org/content-page/current-funding-opportunities-pathway-stop-diabetes
Process for Limited Submissions
PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/. Use the template provided here: RII Limited Submission Applicant Template
Materials to submit include:
- (1) Two-Page Proposal Summary (1” margins; single-spaced; standard font type, e.g. Arial, Helvetica, Times New Roman, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 2-page limit will be excluded from review. You must use the template linked above.
- (2) CV – (5 pages maximum)
Note: The portal requires information about the PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.
Purpose
The Pathway Accelerator award is intended to provide flexible, long-term salary and research support to early career researchers who are proposing innovative and ambitious diabetes-related research programs, and who have distinguished themselves as exceptionally talented and promising research investigators. These awards are highly competitive and intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes with an emphasis on the investigator’s potential to significantly transform diabetes through translational research (‘moving the needle’) to improve the lives of people with diabetes. Candidates for Accelerator awards should be in the process of establishing successful, independent diabetes research programs, and have records of independent productivity in research. For the purpose of this award, demonstration of independent productivity should include that the candidate is currently in an independent faculty position, has demonstrated the ability to perform a particular set of experiments at a high-quality level, including senior author publications (independent of training mentors) and/or has demonstrated the ability to obtain independent funding/support for their work.
Visit our Institutionally Limited Submission webpage for more updates and other announcements.